Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

More Na+/H+-exchange inhibitors from E. Merck

June 14, 1996

Na+/H+-exchange inhibitors from Sumitomo

June 14, 1996

Cardiovascular disorders treatment from Boryung Pharm.

June 14, 1996

Merck & Co. discloses endothelin antagonists

June 14, 1996

Endothelin antagonists from Abbott

June 14, 1996

Tranilast: An angiotensin II antagonist

June 7, 1996

Cytel's cell adhesion inhibitor trial discontinued

June 7, 1996

First chronotherapeutic agent for hypertension and angina now avaliable in U.S.

June 7, 1996

Warner-Lambert reveals indole endothelin antagonists

June 7, 1996

Taisho researchers reveal cGMP-dependent phosphodiesterase (PDE V) inhibitors

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...